# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-20-042738
Filing Date
2020-12-15
Accepted
2020-12-15 14:27:48
Documents
9
Period of Report
2020-12-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | ea131647-8k_aytubioscience.htm | 8-K | 39340
2 | INVESTOR PRESENTATION, DATED DECEMBER 15, 2020 | ea131647ex99-1aytubio.htm | EX-99.1 | 14490
3 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 135954
4 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 252536
5 | GRAPHIC | ex99-1_003.jpg | GRAPHIC | 274274
6 | GRAPHIC | ex99-1_004.jpg | GRAPHIC | 192372
7 | GRAPHIC | ex99-1_005.jpg | GRAPHIC | 404544
8 | GRAPHIC | ex99-1_006.jpg | GRAPHIC | 543917
9 | GRAPHIC | ex99-1_007.jpg | GRAPHIC | 106419
| Complete submission text file | 0001213900-20-042738.txt |  | 2568103

Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 201389239
SIC: 2834 Pharmaceutical Preparations